Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metoprolol in breast cancer surgery
NCT02269696Phase 3Withdrawn
- Sponsor
- Kuopio University Hospital
- Start
- Mar 2018
- Primary completion
- Mar 2018
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of metoprolol in breast cancer, sponsored by Kuopio University Hospital. Planned start Mar 2018; status: withdrawn.
02
Drugs
metoprolol
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02269696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02269696.